Which ASX ETFs hold Charles River Laboratories International Inc (CRL)?
CRL is among the most widely held stocks across ASX-listed ETFs, appearing in approximately 8 ETFs. Its largest single position is approximately 0.25% in HQUS (Betashares S&P 500 Equal Weight Currency Hedged ETF), as at 3 Nov 2026. General information only, not financial advice.
General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
All weights are approximate, drawn from each fund's most recent holdings file (dated 30 Sep 2026 to 3 Nov 2026), and change as funds rebalance.
| ETF | Fund | Category | Weight |
|---|---|---|---|
| HQUS | Betashares S&P 500 Equal Weight Currency Hedged ETF | Thematic | approx. 0.25% |
| QUS | Betashares S&P 500 Equal Weight ETF | Thematic | approx. 0.25% |
| VISM | Vanguard MSCI International Small Companies Index ETF | Global Broad Market | approx. 0.14% |
| UYLD | Global X S&P 500 Covered Call ETF | US Shares | approx. 0.03% |
| SPY | State Street SPDR S&P 500 ETF Trust | US Shares | approx. 0.03% |
| V500 | Vanguard S&P 500 US Shares Index ETF | US Shares | approx. 0.02% |
| V5AH | Vanguard S&P 500 US Shares Index (Hedged) ETF | US Shares | approx. 0.02% |
| VTS | Vanguard US Total Market Shares Index ETF | US Shares | approx. 0.02% |
| VEQ | Vanguard FTSE Europe Shares ETF | Global Broad Market | approx. 0.01% |
Want to see what any of these funds overlap with? Try the free ETF overlap checker, or browse the most widely held stocks.
Hold more than one of these? See your combined CRL exposure across all your ETFs with the Stock X-Ray.
CRL in ETFs: frequently asked questions
Which ASX ETFs hold CRL?
Charles River Laboratories International Inc (CRL) is held by approximately 8 ASX-listed ETFs, including HQUS, QUS, VISM, UYLD, SPY. General information only.
Which ETF has the largest CRL weighting?
HQUS (Betashares S&P 500 Equal Weight Currency Hedged ETF) has the largest CRL position at approximately 0.25% of the fund, as at 3 Nov 2026. Past weightings are not a reliable indicator of future weightings.